Review article · 2026
Brief reportPublished 15 Oct 2016
Cost-effectiveness of Palivizumab in Prevention against RSV Hospitalizations in Risk Groups
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: This study aims to evaluate the costeffectiveness of Palivizumab in preventing Respiratory Syncytial Virus (RSV) infection among risk groups. Methods: Patients enrolled correspond to children aged <2 years admitted in pediatric units of Hotel-Dieu university Hospital (HDF) between January 2014 and January 2016 for RSV infection. We ended up with 32 cases of RSV infection that respond to immunization recommendations and did not receive the prophylaxis. We divided them into 4 groups: Premature babies, those who have congenital heart disease (CHD), those with bronchopulmonary dysplasia (BPD) and those who had more than 2 risk factors. For each group, we compared hospitalization cost to the estimated immune-prophylaxis cost, and we analyzed RSV morbidity in each group. Results: RSV hospitalization among premature babies is the most frequent, hospitalization cost is the highest in babies with pulmonary disease and the group with heart disease is associated to the highest risk of pediatric intensive care unit (PICU) admission. There was no significant statistical difference between hospitalization cost and immunization cost added to consequent presumed hospitalization. Conclusion: For a neutral cost-effectiveness of Palivizumab, immunoprophylaxis reduces RSV hospitalization rate, decreases hospitalization stay, need of oxygen, and PICU transfer along with parental anxiety and work abstention. Palivizumab may be cost-effective in subgroups: prematurity <32 week gestation or cardiac and chronic pulmonary diseases aged less than one year at epidemic RSV season.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pediatric Care.
Short communication · 28 Feb 2025
Telemedicine in Pediatric Care: Opportunities, Limitations and Future Directions
Perspective · 28 Feb 2025
Psychosocial Support in Pediatric Oncology: Enhancing Quality of Life for Children and Families
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pediatric Care
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Elie Choueiry”
- BylineArticles whose byline prints “Bernard Gerbaka”
- BylineArticles whose byline prints “Najib Hanna”
- BylineArticles whose byline prints “Angy Fenianos”
